These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30371303)

  • 1. Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury.
    Shimizu Y; Polavarapu R; Eskla KL; Pantner Y; Nicholson CK; Ishii M; Brunnhoelzl D; Mauria R; Husain A; Naqvi N; Murohara T; Calvert JW
    J Am Heart Assoc; 2018 Oct; 7(19):e009565. PubMed ID: 30371303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.
    Henri O; Pouehe C; Houssari M; Galas L; Nicol L; Edwards-Lévy F; Henry JP; Dumesnil A; Boukhalfa I; Banquet S; Schapman D; Thuillez C; Richard V; Mulder P; Brakenhielm E
    Circulation; 2016 Apr; 133(15):1484-97; discussion 1497. PubMed ID: 26933083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction.
    Houssari M; Dumesnil A; Tardif V; Kivelä R; Pizzinat N; Boukhalfa I; Godefroy D; Schapman D; Hemanthakumar KA; Bizou M; Henry JP; Renet S; Riou G; Rondeaux J; Anouar Y; Adriouch S; Fraineau S; Alitalo K; Richard V; Mulder P; Brakenhielm E
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1722-1737. PubMed ID: 32404007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis.
    Lin QY; Zhang YL; Bai J; Liu JQ; Li HH
    Clin Transl Med; 2021 Mar; 11(3):e374. PubMed ID: 33783987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.
    Heron C; Dumesnil A; Houssari M; Renet S; Lemarcis T; Lebon A; Godefroy D; Schapman D; Henri O; Riou G; Nicol L; Henry JP; Valet M; Pieronne-Deperrois M; Ouvrard-Pascaud A; Hagerling R; Chiavelli H; Michel JB; Mulder P; Fraineau S; Richard V; Tardif V; Brakenhielm E
    Cardiovasc Res; 2023 Mar; 119(2):492-505. PubMed ID: 35689481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangiogenesis, a potential treatment target for myocardial injury.
    Wang YC; Meng WT; Zhang HF; Zhu J; Wang QL; Mou FF; Guo HD
    Microvasc Res; 2023 Jan; 145():104442. PubMed ID: 36206847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms.
    Bai J; Yin L; Yu WJ; Zhang YL; Lin QY; Li HH
    Oxid Med Cell Longev; 2022; 2022():5044046. PubMed ID: 35222798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.
    Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM
    Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43.
    Trincot CE; Xu W; Zhang H; Kulikauskas MR; Caranasos TG; Jensen BC; Sabine A; Petrova TV; Caron KM
    Circ Res; 2019 Jan; 124(1):101-113. PubMed ID: 30582443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
    Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
    Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2b macrophages stimulate lymphangiogenesis to reduce myocardial fibrosis after myocardial ischaemia/reperfusion injury.
    Wang C; Yue Y; Huang S; Wang K; Yang X; Chen J; Huang J; Wu Z
    Pharm Biol; 2022 Dec; 60(1):384-393. PubMed ID: 35188856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
    House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.
    Wang W; McKinnie SM; Patel VB; Haddad G; Wang Z; Zhabyeyev P; Das SK; Basu R; McLean B; Kandalam V; Penninger JM; Kassiri Z; Vederas JC; Murray AG; Oudit GY
    J Am Heart Assoc; 2013 Jul; 2(4):e000249. PubMed ID: 23817469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
    Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor is correlated with peritoneal lymphangiogenesis.
    Kinashi H; Toda N; Sun T; Nguyen TQ; Suzuki Y; Katsuno T; Yokoi H; Aten J; Mizuno M; Maruyama S; Yanagita M; Goldschmeding R; Ito Y
    Sci Rep; 2019 Aug; 9(1):12175. PubMed ID: 31434958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury.
    Smiley D; Smith MA; Carreira V; Jiang M; Koch SE; Kelley M; Rubinstein J; Jones WK; Tranter M
    Cardiovasc Pathol; 2014; 23(6):327-34. PubMed ID: 25035060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions and Regeneration of Mature Cardiac Lymphatic Vessels in Atherosclerosis, Myocardial Infarction, and Heart Failure.
    Zhang Y; Bai Y; Jing Q; Qian J
    Lymphat Res Biol; 2018 Dec; 16(6):507-515. PubMed ID: 30339474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.